首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients
Authors:Liu Xiaowen  Cai Hong  Huang Hua  Long Ziwen  Shi Yingqiang  Wang Yanong
Institution:Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai, China.
Abstract:

Background and Objective

The prognosis varied among the patients with the same stage, therefore there was a need for new prognostic and predictive factors. The aim of this study was to evaluate the relationship of apoptosis-related biological markers such as p53, bcl-2, bax, and c-myc, and clinicopathological features and their prognostic value.

Methods

From 1996 to 2007, 4426 patients had undergone curative D2 gastrectomy for gastric cancer at Fudan University Shanghai Cancer Center. Among 501 patients, the expression levels of p53, bcl-2, bax, and c-myc were examined by immunohistochemistry. The prognostic value of biological markers and the correlation between biological markers and other clinicopathological factors were investigated.

Results

There were 339 males and 162 females with a mean age of 57. The percentages of positive expression of p53, bcl-2, bax, and c-myc were 65%, 22%, 43%, and 58%, respectively. There was a strong correlation between p53, bax, and c-myc expression (P?=?0.00). There was significant association between bcl-2, and bax expression (P<0.05). p53 expression correlated with histological grade (P?=?0.01); bcl-2 expression with pathological stage (P?=?0.00); bax expression with male (P?=?0.02), histological grade (P?=?0.01), Borrmann type (P?=?0.01), tumor location (P?=?0.00), lymph node metastasis (P?=?0.03), and pathological stage (P?=?0.03); c-myc expression with Borrmann type (P?=?0.00). bcl-2 expression was related with good survival in univariate analysis (P?=?0.01). Multivariate analysis showed that bcl-2 expression and pathological stage were defined as independent prognostic factors. There were significant differences of overall 5-year survival rates according to bcl-2 expression or not in stage IIB (P?=?0.03).

Conclusion

The expression of bcl-2 was an independent prognostic factor for patients with gastric cancer; it might be a candidate for the gastric cancer staging system.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号